NEPHROPLUS logo

Nephrocare Health Services Limited Stock Price

NSEI:NEPHROPLUS Community·₹55.4b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

NEPHROPLUS Share Price Performance

₹0
-471.25 (-100.00%)
₹615.00
Fair Value
₹0
-471.25 (-100.00%)
Price ₹0

NEPHROPLUS Community Narratives

AnalystConsensusTarget·
Fair Value ₹615 8.3% undervalued intrinsic discount

Dialysis Demand And International Expansion Will Support A Positive Long Term View

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
₹615
8.3% undervalued intrinsic discount
Revenue
15.28% p.a.
Profit Margin
22.17%
Future PE
31.15x
Price in 2029
₹488.05

Trending Discussion

Updated Narratives

NEPHROPLUS logo

Dialysis Demand And International Expansion Will Support A Positive Long Term View

Fair Value: ₹615 8.3% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

0 Risks
2 Rewards

Nephrocare Health Services Limited Key Details

₹9.5b

Revenue

₹5.8b

Cost of Revenue

₹3.7b

Gross Profit

₹3.0b

Other Expenses

₹713.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
7.11
39.27%
7.49%
36.5%
View Full Analysis

About NEPHROPLUS

Founded
2009
Employees
3448
CEO
Rohit Singh
WebsiteView website
www.nephroplus.com

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.